DNCA FINANCE → BioXcel Therapeutics, Inc. BTAI

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 4.58

3,312,077 shares short · +18.1% vs prior

Other 13D/G Filings on BioXcel Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2020-02-24	SC	DNCA FINANCE	—	—	view →

Other Filings by DNCA FINANCE

Filed	Form	Issuer	Stake	Shares
2023-02-21	SC	Evelo Biosciences, Inc.	—	—	view →
2022-11-21	SC	Evelo Biosciences, Inc.	—	—	view →
2020-02-24	SC	BioXcel Therapeutics, Inc. BTAI	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →